Funder
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. Almeida F, Wolf JM, Casadevall A (2015) Virulence-associated enzymes of Cryptococcus neoformans. Eukaryot Cell 14(12):1173–1185. https://doi.org/10.1128/EC.00103-15
2. Almeida-Paes R, Frases S (2023) Repurposing drugs for fungal infections: advantages and limitations. Future Microbiol. https://doi.org/10.2217/fmb-2023-0108
3. Alves V, Martins PH, Miranda B, de Andrade IB, Pereira L, Maeda CT, de Sousa Araújo GR, Frases S (2023) Assessing the in vitro potential of glatiramer acetate (copaxone®) as a chemotherapeutic candidate for the treatment of Cryptococcus neoformans infection. J Fungi 9(8):783. https://doi.org/10.3390/jof9080783
4. Arendrup MC, Meletiadis J, Mouton JW, Lagrou K, Hamal P, Guinea J, AFST/ESCMID/EUCAST (2017) EUCAST DEFINITIVE DOCUMENT E.DEF 7.3.1. Method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts. 1–21. https://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/AFST/Files/EUCAST_E_Def_7_3_1_Yeast_testing__definitive.pdf
5. Barbosa JO, Rossoni RD, Vilela SFG, De Alvarenga JA, Velloso MDS, Prata MCDA, Jorge AOC, Junqueira JC (2016) Streptococcus mutans can modulate biofilm formation and attenuate the virulence of Candida albicans. PLoS ONE 11(3):e0150457. https://doi.org/10.1371/journal.pone.0150457